基本信息
浏览量:1
职业迁徙
个人简介
My research focuses on immunotherapy in cancer with a special focus on skin cancers such as melanoma. I have designed and conducted numerous Phase I and II clinical trials. A collaboration with Dr Richard Heller has resulted in intratumoral IL12 as a treatment for melanoma. At UCSF, I co-direct the melanoma program and am the PI of several early phase and melanoma specific clinical trials as well as collaborating with my colleagues Michael Rosenblum, Max Krummel, Matt Spitzer and Jeff Bluestone at UCSF as well as other national experts in melanoma patients progressing on immunotherapy. One of the areas I am interested in is immunotherapy with PD-1 antibodies and in understanding resistance to PD-1 especially site specific immunity.
研究兴趣
论文共 420 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 6_Supplement (2024): 6552-6552
Research squareno. 1 (2024): 1-21
Luca G Campana,Adil Daud, Francesco Lancellotti,Julio P Arroyo,Rafael V Davalos,Claudia Di Prata,Julie Gehl
Cancersno. 13 (2023): 3340-3340
Alexandra Haugh,Adil Daud
Cancer immunology researchno. 7 (2023): 864-864
Valentin Feichtenschlager,Li-Nan Chen,Yixuan James Zheng, Won‐Kyung Ho,Martina Sanlorenzo,Igor Vujic,Eleanor Fewings,Albert Lee,Christopher Chen, Ciara Callanan,Kevin Lin,Tiange Qu,
Research Square (Research Square) (2023)
AMERICAN JOURNAL OF TRANSPLANTATIONno. 6 (2023): S466-S467
引用0浏览0引用
0
0
Journal of Clinical Oncology (2023)
引用0浏览0引用
0
0
Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 14 (2023): 2651-+
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): TPS9597-TPS9597
引用0浏览0引用
0
0
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn